Biomarkers of caspofungin resistance in Candida albicans isolates: A proteomic approach

References

• Dutton LC, Paszkiewicz KH, Silverman RJ, et al. Transcriptional landscape of trans-kingdom communication between Candida albicans and Streptococcus gordonii. Mol Oral Microbiol. 2016;31(2):136–161. DOI:10.1111/omi.12111
   PubMed Web of Science ®Google Scholar
• Kumamoto CA. Inflammation and gastrointestinal Candida colonization. Curr Opin Microbiol. 2011;14(4):386–391.
   PubMed Web of Science ®Google Scholar
• Achkar JM, Fries BC. Candida infections of the genitourinary tract. Clin Microbiol Rev. 2010;23(2):253–273.
   PubMed Web of Science ®Google Scholar
• Gow NAR, Hube B. Importance of the Candida albicans cell wall during commensalism and infection. Curr Opin Microbiol. 2012;15(4):406–412.
   PubMed Web of Science ®Google Scholar
• Hernández-Chávez M, Pérez-García L, Niño-Vega G, et al. Fungal strategies to evade the host immune recognition. J Fungi. 2017;3(4):51.
   Web of Science ®Google Scholar
• Gow NAR, Latge J-P, Munro CA. The fungal cell wall: structure, biosynthesis, and function. In: The fungal kingdom. Vol. 5. American Society for Microbiology; 2017. p. 267–292. DOI:10.1128/microbiolspec.funk-0035-2016.
   Google Scholar
• Plaine A, Walker L, Da Costa G, et al. Functional analysis of Candida albicans GPI-anchored proteins: roles in cell wall integrity and caspofungin sensitivity. Fungal Genet Biol. 2008;45(10):1404–1414. DOI:10.1016/j.fgb.2008.08.003
   PubMed Web of Science ®Google Scholar
• Nather K, Munro CA. Generating cell surface diversity in Candida albicans and other fungal pathogens. FEMS Microbiol Lett. 2008;285(2):137–145.
   PubMed Web of Science ®Google Scholar
• Cornely OA, Bassetti M, Calandra T, et al. ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. Clin Microbiol Infect. 2012;18(SUPPL.7):19–37. DOI:10.1111/1469-0691.12039
   PubMed Web of Science ®Google Scholar
• Hope WW, Castagnola E, Groll AH, et al. ESCMID* guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp. for Integrated Oncology CIO KölnBonn, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases. 2012. doi:10.1111/1469-0691.12040
   Google Scholar
• Douglas CM. Fungal beta(1,3)-D-glucan synthesis.Med Mycol. 2001 [cited 2018 July 5];39(Suppl 1):55–66. Availablse from http://www.ncbi.nlm.nih.gov/pubmed/11800269
   PubMed Web of Science ®Google Scholar
• Walker LA, Munro CA. Caspofungin induced cell wall changes of Candida species influences macrophage interactions. Front Cell Infect Microbiol. 2020;10:164.
   PubMed Web of Science ®Google Scholar
• Garcia-Effron G, Park S, Perlin DS. Correlating echinocandin MIC and kinetic inhibition of fks1 mutant glucan synthases for Candida albicans: implications for interpretive breakpoints. Antimicrob Agents Chemother. 2009;53(1):112–122.
   PubMed Web of Science ®Google Scholar
• Garcia-Effron G, Lee S, Park S, et al. Effect of Candida glabrata FKS1 and FKS2 mutations on echinocandin sensitivity and kinetics of 1,3-β-D-glucan synthase: implication for the existing susceptibility breakpoint. Antimicrob Agents Chemother. 2009;53(9):3690–3699.
   PubMed Web of Science ®Google Scholar
• Kelly J, Kavanagh K. Proteomic analysis of proteins released from growth-arrested Candida albicans following exposure to caspofungin. Med Mycol. 2010;48(4):598–605.
   PubMed Web of Science ®Google Scholar
• Yu ZW, Quinn PJ. Solvation effects of dimethyl sulphoxide on the structure of phospholipid bilayers. Biophys Chem. 1998;70(1):35–39.
   PubMed Web of Science ®Google Scholar
• Bdalla AS, de Hoog GS, Stevens DA, et al. Fructose-Bisphosphate aldolase and pyruvate kinase, two novel immunogens in Madurella mycetomatis. Med Mycol. 2015. DOI:10.3109/13693786.2011.593005
   Google Scholar
• Mundodi V, Kucknoor AS, Alderete JF. Immunogenic and plasminogen-binding surface-associated alpha-enolase of Trichomonas vaginalis. Infect Immun. 2008;76(2):523–531.
   PubMed Web of Science ®Google Scholar
• Chumpitazi BFF, Lebeau B, Faure-Cognet O, et al. Characteristic and clinical relevance of Candida mannan test in the diagnosis of probable invasive candidiasis. Med Mycol. 2014;52(5):460–469. DOI:10.1093/mmy/myu018
   Web of Science ®Google Scholar
• Prella M, Bille J, Pugnale M, et al. Early diagnosis of invasive candidiasis with mannan antigenemia and antimannan antibodies. Diagn Microbiol Infect Dis. 2005;51(2):95–101. DOI:10.1016/j.diagmicrobio.2004.08.015
   PubMed Web of Science ®Google Scholar
• Zhao Y, Perlin DS. Use of novel tools to probe drug resistance in Fungi. In: Handbook of antimicrobial resistance; 2017. p. 385–401. DOI:10.1007/978-1-4939-0694-9_21.
   Google Scholar
• Park S, Perlin DS. Establishing surrogate markers for fluconazole resistance in Candida albicans. Microb Drug Resist. 2005;11(3):232–238.
   PubMed Web of Science ®Google Scholar
• Kordalewska M, Lee A, Zhao Y, et al. Detection of Candida auris antifungal drug resistance markers directly from clinical skin swabs. Antimicrob Agents Chemother. 2019;63(12). DOI:10.1128/AAC.01754-19
   Web of Science ®Google Scholar
• Zhao Y, Nagasaki Y, Kordalewska M, et al. Rapid detection of FKS-associated echinocandin resistance in Candida glabrata. Antimicrob Agents Chemother. 2016;60(11):6573–6577. DOI:10.1128/AAC.01574-16
   PubMed Web of Science ®Google Scholar
• Wang D, An N, Yang Y, et al. Candida tropicalis distribution and drug resistance is correlated with ERG11 and UPC2 expression. Antimicrob Resist Infect Control. 2021;10(1):1–9.
   PubMed Web of Science ®Google Scholar
• Amorim-Vaz S, Tran VDT, Pradervand S, et al. RNA enrichment method for quantitative transcriptional analysis of pathogens in vivo applied to the fungus Candida albicans. Mbio. 2015;6(5): e00942-15. DOI:10.1128/mBio.00942-15.
   PubMed Web of Science ®Google Scholar
• Remmele CW, Luther CH, Balkenhol J, et al. Integrated inference and evaluation of host-fungi interaction networks. Front Microbiol. 2015;6:764.
   PubMed Web of Science ®Google Scholar
• Martin R, Albrecht-Eckardt D, Brunke S, et al. A core filamentation response network in Candida albicans is restricted to eight genes. PLoS One. 2013;8(3). DOI:10.1371/journal.pone.0058613
   Web of Science ®Google Scholar
• Fonzi WA, Irwin MY. Isogenic strain construction and gene mapping in Candida albicans.Genetics. 1993 [cited 2017 Apr 6];134(3):717–728. DOI:10.1093/genetics/134.3.717.
   PubMed Web of Science ®Google Scholar
• Gillum AM, Tsay EY, Kirsch DR. Isolation of the Candida albicans gene for orotidine-5’-phosphate decarboxylase by complementation of S. cerevisiae ura3 and E. coli pyrF mutations.Mol Gen Genet. 1984 [cited 2017 Apr 5];198(2):179–182. DOI:10.1007/BF00328721.
   PubMedGoogle Scholar
• Morrison CJ, Hurst SF, Bragg SL, et al. Heterogeneity of the purified extracellular aspartyl proteinase from Candida albicans: characterization with monoclonal antibodies and N-terminal amino acid sequence analysis. Infect Immun. 1993 [cited 2019 Aug 1];61(5):2030–2036. DOI:10.1128/iai.61.5.2030-2036.1993.
   PubMed Web of Science ®Google Scholar
• Thanos M, Schonian G, Meyer W, et al. Rapid identification of Candida species by DNA fingerprinting with PCR. J Clin Microbiol. 1996 [cited 2019 Aug 1];34(3):615–621. DOI:10.1128/jcm.34.3.615-621.1996.
   PubMed Web of Science ®Google Scholar
• Lee KK, MacCallum DM, Jacobsen MD, et al. Elevated cell wall chitin in Candida albicans confers echinocandin resistance in vivo. Antimicrob Agents Chemother. 2012;56(1):208–217. DOI:10.1128/AAC.00683-11
   PubMed Web of Science ®Google Scholar
• M27: reference method for broth dilution antifungal susceptibility testing of yeasts, 4th edition; [ cited 2022 Jan 30]. Avalilable from: https://clsi.org/standards/products/microbiology/documents/m27/
   Google Scholar
• Walker LA, Munro CA, De Bruijn I, et al. Stimulation of chitin synthesis rescues Candida albicans from echinocandins. Cormack BP, ed. PLoS Pathog. 2008;4(4):e1000040.
   PubMed Web of Science ®Google Scholar
• Ramage G, VandeWalle K, Wickes BL, et al. Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms. Antimicrob Agents Chemother. 2001;45(9):2475–2479.
   PubMed Web of Science ®Google Scholar
• Kapteyn JC, Hoyer LL, Hecht JE, et al. The cell wall architecture of Candida albicans wild-type cells and cell wall-defective mutants. Mol Microbiol. 2000;35(3):601–611. DOI:10.1046/j.1365-2958.2000.01729.x
   PubMed Web of Science ®Google Scholar
• Johansson HKL, Svingen T, Boberg J, et al. Calretinin is a novel candidate marker for adverse ovarian effects of early life exposure to mixtures of endocrine disruptors in the rat. Arch Toxicol. 2020;94(4):1241–1250. DOI:10.1007/s00204-020-02697-3
   PubMed Web of Science ®Google Scholar
• Science M. Mascot search engine | Protein identification software for mass spec data; [ cited 2018 Sep 18]. Available from: http://www.matrixscience.com/
   Google Scholar
• Ritchie ME, Phipson B, Wu D, et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47. DOI:10.1093/nar/gkv007
   PubMed Web of Science ®Google Scholar
• Chiquet J, Mariadassou M, Robin S. Variational inference for sparse network reconstruction from count data. 2018.
   Google Scholar
• Rex JH, Alexander BD, Andes D, et al. Reference method for broth dilution antifungal susceptibility testing of yeasts: approved standard - third edition. Clin Lab Stand Inst. 2008;(April):1–25. DOI:10.4319/lo.1981.26.3.0590
   Google Scholar
• Crump JA, Collignon PJ. Intravascular catheter-associated infections.Eur J Clin Microbiol Infect Dis. 2000 [cited 2018 Sep 6];19(1):1–8. DOI:10.1007/s100960050001.
   PubMed Web of Science ®Google Scholar
• Sardi JCO, Scorzoni L, Bernardi T, et al. Candida species: current epidemiology, pathogenicity, biofilms formation, natural antifungal products and new therapeutic options. J Med Microbiol. 2013;62(PART1):10–24.
   PubMedGoogle Scholar
• Frade JP, Arthington-Skaggs BA. Effect of serum and surface characteristics on Candida albicans biofilm formation. Mycoses. 2011;54(4):e154–e162.
   PubMed Web of Science ®Google Scholar
• Berkow EL, Lockhart SR. Fluconazole resistance in Candida species: a current perspective. Infect Drug Resist. 2017;10:237–245.
   PubMed Web of Science ®Google Scholar
• Black RM, Bouffard FA, Plains S. Of all N. USOO5378804A 11 Patent Number: 5. Vol. 378; 1995.
   Google Scholar
• Cornely OA, Bassetti M, Calandra T, et al. ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients for integrated oncology CIO KölnBonn, cologne excel- lence cluster on cellular stress responses in aging-associated diseases. New Microbes New Infect. 2012;18:19–37.
   Google Scholar
• Perlin DS. Resistance to echinocandin-class antifungal drugs. Drug Resist Updat. 2007;10(3):121–130.
   PubMed Web of Science ®Google Scholar
• Park S, Kelly R, Kahn JN, et al. Specific substitutions in the echinocandin target Fks1p account for reduced susceptibility of rare laboratory and clinical Candida sp. isolates. Antimicrob Agents Chemother. 2005;49(8):3264–3273. DOI:10.1128/AAC.49.8.3264-3273.2005
   PubMed Web of Science ®Google Scholar
• Desnos-Ollivier M, Bretagne S, Raoux D, et al. Mutations in the fks1 gene in Candida albicans, C. tropicalis, and C. krusei correlate with elevated caspofungin MICs uncovered in AM3 medium using the method of the European committee on antibiotic susceptibility testing. Antimicrob Agents Chemother. 2008;52(9):3092–3098.
   PubMed Web of Science ®Google Scholar
• Fonzi WA. PHR1 and PHR2 of Candida albicans encode putative glycosidases required for proper cross-linking of beta-1,3- and beta-1,6-glucans.J Bacteriol. 1999 [cited 2019 Aug 20];181(22):7070–7079. DOI:10.1128/JB.181.22.7070-7079.1999.
   PubMed Web of Science ®Google Scholar
• Pardini G, De Groot PWJ, Coste AT, et al. The CRH family coding for cell wall glycosylphosphatidylinositol proteins with a predicted transglycosidase domain affects cell wall organization and virulence of Candida albicans. J Biol Chem. 2006;281(52):40399–40411. DOI:10.1074/jbc.M606361200
   PubMed Web of Science ®Google Scholar
• Consortium O, Gabaldón T, Butler G, et al. Recent trends in molecular diagnostics of yeast infections: from PCR to NGS. FEMS Microbiol Rev. 2019;43(5):517–547. DOI:10.1093/femsre/fuz015.
   PubMed Web of Science ®Google Scholar
• Li L, Liao Z, Yang Y, et al. Metabolomic profiling for the identification of potential biomarkers involved in a laboratory azole resistance in Candida albicans. PLoS One. 2018;13(2). DOI:10.1371/JOURNAL.PONE.0192328
   Web of Science ®Google Scholar
• Flores-Treviño S, Garza-González E, Mendoza-Olazarán S, et al. Screening of biomarkers of drug resistance or virulence in ESCAPE pathogens by MALDI-TOF mass spectrometry. Sci Reports 2019 91. 2019;9(1):1–10.
   Google Scholar
• Maus A, Bisha B, Fagerquist C, et al. Detection and identification of a protein biomarker in antibiotic resistant E. coli using intact protein LC offline MALDI-MS and MS/MS. J Appl Microbiol. 2020;128(3):697.
   PubMed Web of Science ®Google Scholar
• Rajendran R, Sherry L, Nile CJ, et al. Biofilm formation is a risk factor for mortality in patients with Candida albicans bloodstream infection-Scotland, 2012-2013. Clin Microbiol Infect. 2016;22(1):87–93. DOI:10.1016/j.cmi.2015.09.018
   PubMed Web of Science ®Google Scholar